Cart
sales@molnova.com
Cyclo(RGDfK)
CAS No. 161552-3-0
Cyclo(RGDfK)( —— )
Catalog No. M21723 CAS No. 161552-3-0
Cyclo(RGDfK) is a synthetic lipopeptide inhibitor of αvβ3 integrin (IC50 = 1.33 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 136 | In Stock |
|
| 10MG | 232 | In Stock |
|
| 25MG | 462 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCyclo(RGDfK)
-
NoteResearch use only, not for human use.
-
Brief DescriptionCyclo(RGDfK) is a synthetic lipopeptide inhibitor of αvβ3 integrin (IC50 = 1.33 nM).
-
DescriptionCyclo(RGDfK) is a synthetic lipopeptide inhibitor of αvβ3 integrin (IC50 = 1.33 nM). Osteoblast cultures, which express αvβ5 and αvβ3 integrins, but not M21L cells that do not express these integrins, bind to cyclo(RGDfK)-coated surfaces. Cyclo(RGDfK) is taken up into tumors in vivo and in vitro and it has been polymerized or conjugated to various fluorophores, radiolabels, and peptide sequences for use in fluorescent and PET imaging to study tumor cell adhesion.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
Recptorαvβ3 integrin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number161552-3-0
-
Formula Weight717.69
-
Molecular FormulaC29H42F3N9O9
-
Purity>98% (HPLC)
-
SolubilityWater,100 mg/mL (139.34 mM)
-
SMILESC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CCCCN)CC2=CC=CC=C2)CC(=O)O.C(=O)(C(F)(F)F)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. ?ime?ek, J., Notni, J., Kapp, T.G., et al. Benefits of NOPO as chelator in gallium-68 peptides, exemplified by preclinical characterization of 68Ga-NOPO-c(RGDfK). Mol. Pharm. 11(5), 1687-1695 (2014).
2. Dijkgraaf, I., Beer, A.J., and Wester, H.-J. Application of RGD-containing peptides as imaging probes for alphavbeta3 expression. Front. Biosci. (Landmark Ed.) 14, 887-899 (2009).
molnova catalog
related products
-
ML165
A high-affinity, selective platelet integrin αIIbβ3 receptor antagonist with IC50 of 96 nM.
-
RGD peptide GRGDNP
RGD peptide (GRGDNP) acts as an inhibitor of integrin-ligand interactions and can induce apoptosis in the absence of signals and integrin-mediated cell clustering.
-
Volociximab
Volociximab (M200) is an IgG4 monoclonal antibody targeting the α5β1 integrin , with antiangiogenic, antitumor and anticancer activity, inhibits the growth of rabbit VX2 tumors and is used to study solid tumors.
